<DOC>
	<DOCNO>NCT02781285</DOCNO>
	<brief_summary>The researching subject aim obtain clinical evidence ( include real benefits， risk , etc . ) traditional Chinese medicine treatment advance gastric cancer compare outcomes accept traditional Chinese medicine . subject acquire clinical practice use method multicenter、persisting registry ( real world research technology ) propensity score .</brief_summary>
	<brief_title>Effect Study Clinical Outcomes Traditional Chinese Medicine Advanced Gastric Cancer Propensity Score</brief_title>
	<detailed_description>The purpose project evaluate role traditional Chinese medicine treatment advance gastric cancer clinical registration along real world study . The patient suffer advanced gastric cancer often short time survival . Their total survival time 4.3 month best supportive care . At present palliative chemotherapy still main method advance gastric cancer . In recent year , result international multi center phase III clinical trial show patient combination chemotherapy 8.6 month 13.0 month survival time . In China , clinical curative effect traditional Chinese medicine treatment advance gastric cancer part affirmation . Some report large sample clinical research show Traditional Chinese Medicine may prolong survival improve quality life patient advance gastric cancer . Real World Study emphasize epidemiological theory , clinical observational study , cross-sectional study cohort study . The observational study registry ( registry study clinical practice ) particularly widely use . Clinical practice traditional Chinese medicine treatment advance gastric cancer often rely accumulation year medical experience sometimes new treatment measure . There must objective evidence reasonable design , rigorous process , scientific statistic evaluate value traditional Chinese medicine intervention comprehensive treatment advance gastric cancer patient order meet need clinical practice medical development China .</detailed_description>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<criteria>gastric adenocarcinoma without operation recurrence operation metastasis diagnose within three month KPS score≥60 expect survival time 3 month HB ≥80g/L 、WBC≥4.0×109/L、 N ≥2.0×109/L 、PLA ≥80×109/L normal function heart 、kidney liver gastric adenocarcinoma simultaneous diagnosis malignant tumor participate clinical trial new drug list China combine myocardial infarction , cerebral infarction , severe liver kidney dysfunction , postoperative severe complication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>